Literature DB >> 9660791

A new tyrosine-phosphorylated 97-kDa adaptor protein mediates interleukin-2-induced association of SHP-2 with p85-phosphatidylinositol 3-kinase in human T lymphocytes.

F Gesbert1, C Guenzi, J Bertoglio.   

Abstract

Interleukin (IL)-2 is a major cytokine that controls differentiation and proliferation of T lymphocytes. In this report we characterize an as yet unidentified 97-kDa protein that is a major tyrosine kinase substrate in IL-2-stimulated cells. pp97 was found to associate with the p85.p110 phosphatidylinositol 3-kinase complex, the Src homology 2 (SH2) domain-containing tyrosine phosphatase SHP-2, and the adaptor molecules CrkL and Grb2. We demonstrate that these interactions are directly mediated through the SH2 domains of CrkL, p85, and SHP-2 and through the SH3 domains of Grb2. pp97 was found to mediate the IL-2-induced interaction between p85 and both a phosphorylated and a non-phosphorylated form of SHP-2. In this study we show that pp97 behaves as a docking protein and associates with at least CrkL, p85, and SHP-2 in the same multimolecular complex. We thus characterized pp97 as a new tyrosine kinase substrate in human T lymphocytes which might play a central role in the regulation of several pathways activated by IL-2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9660791     DOI: 10.1074/jbc.273.29.18273

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB.

Authors:  M M Georgescu; K H Kirsch; T Shishido; C Zong; H Hanafusa
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

2.  New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway.

Authors:  H Gu; H Maeda; J J Moon; J D Lord; M Yoakim; B H Nelson; B G Neel
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.

Authors:  Mary Arnaud; Rym Mzali; Franck Gesbert; Catherine Crouin; Christine Guenzi; Claudine Vermot-Desroches; John Wijdenes; Geneviève Courtois; Olivier Bernard; Jacques Bertoglio
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

Review 4.  Involvement of crk adapter proteins in regulation of lymphoid cell functions.

Authors:  Sigal Gelkop; Yael Babichev; Rachel Kalifa; Ami Tamir; Noah Isakov
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

5.  Ectodomain shedding of interleukin-2 receptor beta and generation of an intracellular functional fragment.

Authors:  Pavel Montes de Oca; Valerie Malardé; Richard Proust; Alice Dautry-Varsat; Franck Gesbert
Journal:  J Biol Chem       Date:  2010-05-21       Impact factor: 5.157

6.  Gab adapter proteins as therapeutic targets for hematologic disease.

Authors:  Sheetal Verma; Tamisha Vaughan; Kevin D Bunting
Journal:  Adv Hematol       Date:  2011-12-14

7.  The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.

Authors:  Leslie Yewakon Gandji; Richard Proust; Lionel Larue; Franck Gesbert
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

Review 8.  SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling.

Authors:  Charlène Niogret; Walter Birchmeier; Greta Guarda
Journal:  Front Immunol       Date:  2019-10-25       Impact factor: 7.561

9.  The adaptor protein SAP directly associates with CD3ζ chain and regulates T cell receptor signaling.

Authors:  Richard Proust; Jacques Bertoglio; Franck Gesbert
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

10.  Changes in Gab2 phosphorylation and interaction partners in response to interleukin (IL)-2 stimulation in T-lymphocytes.

Authors:  Nerea Osinalde; Virginia Sánchez-Quiles; Blagoy Blagoev; Irina Kratchmarova
Journal:  Sci Rep       Date:  2016-03-30       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.